European shares hit a two-week low on Wednesday as higher stock valuations continued to make global investors nervous, while Novo Nordisk slumped after the drugmaker made a gloomy forecast. The pan-European STOXX 600 index fell 0.4% to 568.10 as of 0811 GMT, trading at levels last seen on October 17 for a second straight session. […]
